Global health & medicine最新文献_第9页

Prevalence of transmitted drug resistance and phylogenetic analysis of HIV-1 among antiretroviral therapy-naïve patients in Northern Vietnam from 2019 to 2022. 2019年至2022年越南北部抗逆转录病毒疗法无效患者的HIV-1传播耐药性流行率和系统发育分析。

IF 2.6

Global health & medicine Pub Date : 2024-04-30 DOI: 10.35772/ghm.2023.01112

Giang Van Tran, Tsunefusa Hayashida, An Luong-Dieu Dang, Moeko Nagai, Shoko Matsumoto, Linh Khanh Tran, Hoa Nguyen-Minh Le, Trang Dinh Van, Junko Tanuma, Thach Ngoc Pham, Shinichi Oka

{"title":"Prevalence of transmitted drug resistance and phylogenetic analysis of HIV-1 among antiretroviral therapy-naïve patients in Northern Vietnam from 2019 to 2022.","authors":"Giang Van Tran, Tsunefusa Hayashida, An Luong-Dieu Dang, Moeko Nagai, Shoko Matsumoto, Linh Khanh Tran, Hoa Nguyen-Minh Le, Trang Dinh Van, Junko Tanuma, Thach Ngoc Pham, Shinichi Oka","doi":"10.35772/ghm.2023.01112","DOIUrl":"https://doi.org/10.35772/ghm.2023.01112","url":null,"abstract":"Since the rapid expansion of antiretroviral therapy (ART) for HIV, transmitted drug resistance (TDR) has become a major concern in Vietnam. HIV services there are transitioning to be covered by social insurance. Access to pre-exposure prophylaxis (PrEP) is being expanded to tackle the growing HIV epidemic among men who have sex with men. Therefore, a cross-sectional study was conducted at 10 ART facilities in Northern Vietnam from 9th December 2019 to 9th June 2022 to investigate the prevalence and pattern of TDR among ART-naïve people living with HIV (PLWH). TDR mutations were defined according to the World Health Organization 2009 List of Mutations for Surveillance of Transmitted Drug Resistant HIV Strains. Mutation transmission dynamics and TDR clusters were investigated via phylogenetic analysis. We enrolled 391 ART-naïve PLWH. The overall TDR prevalence was 4.6%, with an annual prevalence of 6.0% in 2019/2020, 4.8% in 2021, and 1.3% in 2022. TDR mutations to non-nucleoside reverse transcriptase inhibitors (2.8%), including K103N were the most common. Less commonly, the protease inhibitor-associated mutation M46I and mutations to nucleoside reverse transcriptase inhibitors, including M184V/ I, were observed. CRF01_AE was the most common subtype (77.0%). CRF07_BC (14.3%), which had been rare in Vietnam, was also observed. No genetic association was observed between HIV-1 sequences with TDR mutations. In conclusion, the overall prevalence of TDR was stably low in this region. The phylogenetic tree suggests that TDR clusters have not formed. Continuous monitoring of HIV TDR and strains is crucial to maintaining ART and PrEP efficacy.","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 2","pages":"117-123"},"PeriodicalIF":2.6,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11043122/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140849971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Knowledge, attitudes, practices and prevalence of hepatitis B and C and hepatitis B vaccination coverage among public sector healthcare workers in Cambodia. 柬埔寨公共部门医护人员对乙型肝炎和丙型肝炎的认识、态度、做法和流行率以及乙型肝炎疫苗接种覆盖率。

IF 1.9

Global health & medicine Pub Date : 2024-04-30 DOI: 10.35772/ghm.2023.01097

Youlet By, Linh-Vi Le, Sovanthida Suy, Monidarin Chou, Po-Lin Chan, Kanika Heng, Socheata Phou, Chanthou Ny, Serongkea Deng, Chan Leakhena Phoeung, Sovatha Mam, Laurent Ferradini, François-Xavier Babin, Vonthanak Saphonn

{"title":"Knowledge, attitudes, practices and prevalence of hepatitis B and C and hepatitis B vaccination coverage among public sector healthcare workers in Cambodia.","authors":"Youlet By, Linh-Vi Le, Sovanthida Suy, Monidarin Chou, Po-Lin Chan, Kanika Heng, Socheata Phou, Chanthou Ny, Serongkea Deng, Chan Leakhena Phoeung, Sovatha Mam, Laurent Ferradini, François-Xavier Babin, Vonthanak Saphonn","doi":"10.35772/ghm.2023.01097","DOIUrl":"10.35772/ghm.2023.01097","url":null,"abstract":"Healthcare workers (HCWs) are a key population at high risk for hepatitis B (HBV) and hepatitis C (HCV) infections. We aim to study HBV vaccination coverage, seroprevalence, knowledge, attitudes, and practices towards HBV and HCV infections among HCWs in public sector in Cambodia. A nationally representative cross-sectional study was implemented in 2019, among Cambodian HCWs. A standardized questionnaire was administered to randomly selected HCWs whose blood was then sampled. We used univariate and multivariate regression to determine predictors of outcomes. Among 755 participants, we found 4.9% positive HBsAg and 2.3% positive anti-HCV Ab. HBV vaccination coverage was 59.3%. Lack of knowledge was found on the route of transmission, HBV vaccination, diagnosis and treatment of HBV and HCV. 67% of HCWs thought that all patients should be screened for HBV and HCV and about 30% of them would refuse to take care of infected patients. 58% of HCWs always recapped the needle after use. In univariate analysis, older age-group (> 50 years) is more likely to have positive anti-HCV (OR: 9.48; 95% CI: 2.36-38.18). HCWs who were younger, female or having higher education or having ever been tested, were more likely to have gotten HBV vaccinated. Multivariate analysis reconfirmed these predictors of getting vaccinated. Study findings indicated an urgent need of a national policy for Cambodian HCWs given the high prevalence of hepatitis among this group. Policy should include an effective in-service training program to improve knowledge and practices, a testing and vaccination program for HCWs and it should emphasize stigma intervention towards people living with HBV/HCV.","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 2","pages":"108-116"},"PeriodicalIF":1.9,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11043119/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140858155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Crisis management for the future: Building a platform to provide information on emerging and re-emerging infectious diseases from normal times in Japan. 面向未来的危机管理：建立一个平台，提供有关日本平时新出现和再次出现的传染病的信息。

IF 2.6

Global health & medicine Pub Date : 2024-04-30 DOI: 10.35772/ghm.2023.01089

Eisuke Adachi, Amato Otani, Hiroshi Yotsuyanagi, Masayuki Saijo, Tomoya Saito

引用次数: 0

Prevalence, characteristics, and virologic correlations of hepatitis delta (D) among patients with hepatitis B surface antigen in Mongolia. 蒙古乙型肝炎表面抗原患者中三角肝炎 (D) 的流行率、特征和病毒学相关性。

IF 2.6

Global health & medicine Pub Date : 2024-04-30 DOI: 10.35772/ghm.2023.01080

Sarantuya Gidaagaya, Akinori Rokuhara, Masaya Sugiyama, Sumiya Dorj, Batnasan Barsuren, Bira Namdag, Batmunkh Munkhbat, Shinichi Oka, Masashi Mizokami

{"title":"Prevalence, characteristics, and virologic correlations of hepatitis delta (D) among patients with hepatitis B surface antigen in Mongolia.","authors":"Sarantuya Gidaagaya, Akinori Rokuhara, Masaya Sugiyama, Sumiya Dorj, Batnasan Barsuren, Bira Namdag, Batmunkh Munkhbat, Shinichi Oka, Masashi Mizokami","doi":"10.35772/ghm.2023.01080","DOIUrl":"https://doi.org/10.35772/ghm.2023.01080","url":null,"abstract":"Clinical and biochemical features of hepatitis delta virus (HDV) infections in Mongolia remain largely unknown. We aimed to investigate the clinical characteristics of HDV patients in Mongolia using several markers. The 143 hepatitis B surface antigen (HBsAg)-positive patients were divided into 122 HDV-positive and 21 HDV-negative patients by HDV RNA positivity. Subgroup analysis was performed between hepatitis B e antigen (HBeAg)-positive and -negative HDV-positive patients. Liver function, quantitative HBsAg (qHBsAg), anti-HDV Immunoglobulin (Ig) M, Mac-2 binding protein glycosylation isomer (M2BPGi), hepatitis B virus (HBV) DNA level, and HDV RNA level were tested. HDV RNA was positive in 85.3% (122/143) of patients showing anti-HDV IgG. Liver disease activity was higher in HDV-positive patients than in HDV-negative patients. The HDV-positive group included a higher proportion of patients with high qHBsAg and M2BPGi levels (p < 0.001). The positivity rate for anti-HDV IgM was significantly higher in the HDV-positive group (p < 0.001). HDV RNA levels showed an inverse correlation with qHBsAg levels in HBeAg-positive-HDV-positive patients (r = -0.49, p = 0.034), and a positive correlation with qHBsAg levels in HBeAg-negative patients (r = 0.35, p < 0.001). Hepatitis B virus (HBV) DNA and HDV RNA levels did not show any correlation. M2BPGi levels likewise did not correlate with HDV RNA levels. A high positivity rate for HDV RNA was observed for HBV patients in Mongolia using the highly sensitive HDV RNA assay. The positivity rate for anti-HDV IgM was high in HDV RNA-positive patients. Severity of liver disease and M2BPGi levels were both high in the HDV RNA-positive group.","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 2","pages":"101-107"},"PeriodicalIF":2.6,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11043131/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140847477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Decreased resting-state functional connectivity and brain network abnormalities in the prefrontal cortex of elderly patients with Parkinson's disease accompanied by depressive symptoms. 伴有抑郁症状的帕金森病老年患者前额叶皮层静息态功能连接性降低和大脑网络异常。

IF 2.6

Global health & medicine Pub Date : 2024-04-30 DOI: 10.35772/ghm.2023.01043

Bingjie Tian, Qing Chen, Min Zou, Xin Xu, Yuqi Liang, Yiyan Liu, Miaomiao Hou, Jiahao Zhao, Zhenguo Liu, Liping Jiang

{"title":"Decreased resting-state functional connectivity and brain network abnormalities in the prefrontal cortex of elderly patients with Parkinson's disease accompanied by depressive symptoms.","authors":"Bingjie Tian, Qing Chen, Min Zou, Xin Xu, Yuqi Liang, Yiyan Liu, Miaomiao Hou, Jiahao Zhao, Zhenguo Liu, Liping Jiang","doi":"10.35772/ghm.2023.01043","DOIUrl":"https://doi.org/10.35772/ghm.2023.01043","url":null,"abstract":"This study aimed to explore the brain network characteristics in elderly patients with Parkinson's disease (PD) with depressive symptoms. Thirty elderly PD patients with depressive symptoms (PD-D) and 26 matched PD patients without depressive symptoms (PD-NOD) were recruited based on HAMD-24 with a cut-off of 7. The resting-state functional connectivity (RSFC) was conducted by 53-channel functional near-infrared spectroscopy (fNIRS). There were no statistically significant differences in MMSE scores, disease duration, Hoehn-Yahr stage, daily levodopa equivalent dose, and MDS-UPDRS III between the two groups. However, compared to the PD-NOD group, the PD-D group showed significantly higher MDS-UPDRS II, HAMA-14, and HAMD-24. The interhemispheric FC strength and the FC strength between the left dorsolateral prefrontal cortex (DLPFC-L) and the left frontal polar area (FPA-L) was significantly lower in the PD-D group (FDR p < 0.05). As for graph theoretic metrics, the PD-D group had significantly lower degree centrality (aDc) and node efficiency (aNe) in the DLPFC-L and the FPA-L (FDR, p < 0.05), as well as decreased global efficiency (aEg). Pearson correlation analysis indicated moderate negative correlations between HAMD-24 scores and the interhemispheric FC strength, FC between DLPFC-L and FPA-L, aEg, aDc in FPA-L, aNe in DLPFC-L and FPA-L. In conclusion, PD-D patients show decreased integration and efficiency in their brain networks. Furthermore, RSFC between DLPFC-L and FPA-L regions is negatively correlated with depressive symptoms. These findings propose that targeting DLPFC-L and FPA-L regions via non-invasive brain stimulation may be a potential intervention for alleviating depressive symptoms in elderly PD patients.","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 2","pages":"132-140"},"PeriodicalIF":2.6,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11043130/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140861847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevention of cardiovascular disease, a major non-communicable disease, in a super-aging society: Health success and unsolved issues in Japan. 在超老龄化社会中预防心血管疾病这一主要非传染性疾病：日本在健康方面取得的成功和尚未解决的问题。

IF 2.6

Global health & medicine Pub Date : 2024-02-29 DOI: 10.35772/ghm.2023.01130

Hiroyasu Iso

{"title":"Prevention of cardiovascular disease, a major non-communicable disease, in a super-aging society: Health success and unsolved issues in Japan.","authors":"Hiroyasu Iso","doi":"10.35772/ghm.2023.01130","DOIUrl":"10.35772/ghm.2023.01130","url":null,"abstract":"As far as non-communicable disease is concerned, Japan is unique in showing a substantial decline in stroke mortality and the lowest and declining mortality from ischemic heart disease during the past half century, which contributed to the elongation of a 4-year average life expectancy, leading to top longevity in the world. However, several issues have remained in the prevention of cardiovascular disease with super-aging: i) how to manage the screening and lifestyle modification for both individuals with metabolic syndrome and those with non-overweight/ obesity plus metabolic risk factors, and ii) how to enhance the referral of very high-risk individuals screened at health checks to physicians for seeking treatment and examine whether an early clinical visit was associated with a lower risk of cardiovascular disease and total mortality. Health counseling is needed for both persons with metabolic syndrome and high-risk individuals with non-obese/overweight because the population attributable risk fraction of ischemic cardiovascular disease was similar for both high-risk individuals. Standardized counseling for very high-risk individuals accelerated clinical visits and reduced levels of risk factors. In health counseling, public health nurses were more effective in increasing clinic visits. Furthermore, the earlier clinic visit after the counseling suggested a lower risk of hospitalization for stroke, coronary heart disease, heart failure, and all-cause mortality. This article reviews these epidemiological findings for health practitioners and policymakers to perform further prevention and control for cardiovascular disease in Japan and other Asian and African countries with emerging cardiovascular burden and aging.","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 1","pages":"33-39"},"PeriodicalIF":2.6,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10912808/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140049197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Senility deaths in aged societies: The case of Japan. 老年社会中的老年痴呆死亡：日本的情况。

IF 2.6

Global health & medicine Pub Date : 2024-02-29 DOI: 10.35772/ghm.2023.01127

Reiko Hayashi, Teruhiko Imanaga, Eiji Marui, Hiroshi Kinoshita, Futoshi Ishii, Emiko Shinohara, Motomi Beppu

{"title":"Senility deaths in aged societies: The case of Japan.","authors":"Reiko Hayashi, Teruhiko Imanaga, Eiji Marui, Hiroshi Kinoshita, Futoshi Ishii, Emiko Shinohara, Motomi Beppu","doi":"10.35772/ghm.2023.01127","DOIUrl":"10.35772/ghm.2023.01127","url":null,"abstract":"Senility is now the third largest cause of death in Japan, comprising 11.4% of the total number of deaths in 2022. Although senility deaths were common in the period before the Second World War, they declined sharply from 1950 to 2000 and then increased up to the present. The recent increase is more than what we could expect from an increasing number of very old persons or the increasing number of deaths at facilities. The senility death description in the death certificate is becoming poorer, with 93.8% of them only with a single entry of \"senility\". If other diseases are mentioned, those are again vague diseases or conditions. Senility, dementia and Alzheimer's disease, sequelae of cerebrovascular disease, and heart failure are the largest causes of death in which senility is mentioned in the death certificate. The period from senility onset to death is often described within a few months, but it varies. In some cases, the deceased's age was written out of a conviction that the ageing process starts from birth. As senility is perceived differently among the certifying doctors, a standardised protocol to certify the senility death is needed. On the other hand, senility death is the preferred cause of death and many people do not wish to receive invasive medical examinations before dying peacefully. Together with other causes of death related to frailty, there would be a need to capture senility as a proper cause of death, not just as a garbage code, in the aged, low-mortality population.","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 1","pages":"40-48"},"PeriodicalIF":2.6,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10912805/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140049199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Exploring the contribution of Japan's experience in addressing rapid aging in Asia: Focus on dementia care. 探讨日本在应对亚洲快速老龄化方面的经验贡献：聚焦老年痴呆症护理。

IF 2.6

Global health & medicine Pub Date : 2024-02-29 DOI: 10.35772/ghm.2023.01124

Hiroko Baba, Myo Nyein Aung, Ayumi Miyagi, Ayako Masu, Yuta Yokobori, Hiroyuki Kiyohara, Eriko Otake, Motoyuki Yuasa

{"title":"Exploring the contribution of Japan's experience in addressing rapid aging in Asia: Focus on dementia care.","authors":"Hiroko Baba, Myo Nyein Aung, Ayumi Miyagi, Ayako Masu, Yuta Yokobori, Hiroyuki Kiyohara, Eriko Otake, Motoyuki Yuasa","doi":"10.35772/ghm.2023.01124","DOIUrl":"10.35772/ghm.2023.01124","url":null,"abstract":"This review article explores the potential contribution of Japan's experience in addressing rapid aging in Asia with a specific focus on dementia care. As Japan is a frontrunner in terms of aging society, we consider valuable insights and lessons from Japanese policy history and reflect on its contribution. The World Health Organization, Regional Office for the Western Pacific Regional Action Plan on Healthy Ageing for the Western Pacific was compared with the Japanese \"Outline for Promotion of Dementia Policies\". The following five issues were discussed: i) improving awareness of dementia and community engagement in Japan from a mutual aid perspective; ii) social activities for prevention of dementia at the local level; iii) human resources for medical and long-term care; iv) local coordinators for old people care at home to evaluate the needs for care and tailor the care-plan on an individual basis; v) research and development of long-term care products. Given these factors, it is important to address the aging society through a combined cross-sectoral approach, including policy, research, development of care products, community, and education of care workers. Aging population measures in Japan do not provide a definitive answer, which prompts the consideration of better solutions derived from Japan's trial and error. The aging rate of 7%, 14%, and 21% are commonly used in international comparisons as indicators of the speed of the aging process, but before this 7% is reached, policies tailored to each country should be considered.","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 1","pages":"19-32"},"PeriodicalIF":2.6,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10912802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140049194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Japan's healthcare delivery system: From its historical evolution to the challenges of a super-aged society. 日本的医疗保健服务体系：从历史演变到超高龄社会的挑战。

IF 2.6

Global health & medicine Pub Date : 2024-02-29 DOI: 10.35772/ghm.2023.01121

Teruyuki Katori

{"title":"Japan's healthcare delivery system: From its historical evolution to the challenges of a super-aged society.","authors":"Teruyuki Katori","doi":"10.35772/ghm.2023.01121","DOIUrl":"10.35772/ghm.2023.01121","url":null,"abstract":"Although Japan's healthcare delivery system is highly regarded internationally, the COVID-19 pandemic has exposed its structural problems. Behind these issues lies a history of medical care provisions supported mainly by an unrestricted, \"free labeling\" system, and independently financed private hospitals. In addition, patients have a high degree of freedom of choice under the Japanese medical insurance system, making it difficult to provide comprehensive and continuous health management from initial diagnosis and treatment (primary care), specialized treatment, to supporting a return to home, providing nursing care and lifestyle support. As Japan becomes a \"super-aged\" society with individuals over 65 making up over 30% of the population, the nature of medical care will have to undergo major changes. Medical care's basic function must still be the treatment and cure of patients, but the system will also have to provide support. That means conceiving of care in a way that treats a person's life with dignity and does not sacrifice life for treatment. The implementation of a family doctor function and the clarification of the functions and roles of small and medium-sized community-based hospitals that support this function, as well as the establishment of a community comprehensive care network with multidisciplinary cooperation that goes beyond medical care, should also be set forth in future regional medical care plans.","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 1","pages":"6-12"},"PeriodicalIF":2.6,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10912799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140049196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Utilization of Japanese long-term care-related data including Kaigo-DB: An analysis of current trends and future directions. 日本长期护理相关数据（包括 Kaigo-DB）的利用：当前趋势和未来方向分析。

IF 2.6

Global health & medicine Pub Date : 2024-02-29 DOI: 10.35772/ghm.2023.01135

Taeko Watanabe, Nanako Tamiya

{"title":"Utilization of Japanese long-term care-related data including Kaigo-DB: An analysis of current trends and future directions.","authors":"Taeko Watanabe, Nanako Tamiya","doi":"10.35772/ghm.2023.01135","DOIUrl":"10.35772/ghm.2023.01135","url":null,"abstract":"Despite high expectations from the government and researchers regarding data utilization, comprehensive analysis of long-term care (LTC)-related data use has been limited. This study reviewed the use of LTC-related data, including Kaigo-DB, in Japan after 2020. There was an increase in studies using LTC-related data in Japan between 2020 and 2021, followed by a stabilization period. The national government provided 13.5% of this data (6.5% from Kaigo-DB), while prefectures and municipalities contributed 85.2%, and facilities provided 1.3%. The linked data used in 90.4% of the studies primarily consisted of original questionnaire or interview surveys (34.6%) and medical claims (34.0%). None of the studies based on Kaigo-DB utilized linked data. In terms of study design, cohort studies were the most common (84.6%), followed by descriptive (5.1%), cross-sectional (3.2%), and case-control studies (1.3%). Among the 138 individual-based analytical descriptive studies, the most frequently used LTC-related data as an exposure was LTC services (26.8%), and the most common data used as an outcome was LTC certification or care need level (43.5%), followed by the independence degree of daily living for the older adults with dementia (18.1%). To enhance the use of LTC-related data, especially the valuable national Kaigo-DB, insights can be gleaned from how researchers effectively utilize municipal and prefectural data. Streamlining access to Kaigo-DB and enabling its linkage with other datasets are promising for future research in this field.","PeriodicalId":12556,"journal":{"name":"Global health & medicine","volume":"6 1","pages":"63-69"},"PeriodicalIF":2.6,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10912809/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140051470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0